Seeking Alpha

Baxter International (BAX -0.5%) says the results from two large, international multicenter...

Baxter International (BAX -0.5%) says the results from two large, international multicenter trials it conducted show that a low glucose peritoneal dialysis regimen favorably impacted metabolic measures important for end-stage renal disease patients with diabetes, including blood glucose control and selected lipids. The combined results were presented at the 49th Annual European Renal Association - European Dialysis and Transplant Association congress in Paris.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)